1 / 14

Design and Analysis of Crossover Study Designs

Design and Analysis of Crossover Study Designs. Bhargava Kandala Department of Pharmaceutics College of Pharmacy , UF. Crossover Study. Treatments administered in a sequence to each experimental unit over a set of time periods. Comparison of treatments on a within-subject level.

rickwilson
Télécharger la présentation

Design and Analysis of Crossover Study Designs

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Design and Analysis of Crossover Study Designs Bhargava Kandala Department of Pharmaceutics College of Pharmacy , UF

  2. Crossover Study • Treatments administered in a sequence to each experimental unit over a set of time periods. • Comparison of treatments on a within-subject level. • Increased precision of treatment comparisons. • A treatment given in one period might influence the response in the following treatment period – residual/carryover effect • Baseline values – Can be included as covariates to increase the precision

  3. Period 1 (q.d.) Period 2 (q.d.) Period 3 (q.d.) Baseline 1 Baseline 2 Low Low Low Baseline 3 Washout Washout Study Design Medium Medium Medium Subjects = 10 Randomization High High High • Single center, double blind, randomized, 3 period, 3 treatment, 3 sequence crossover study PD Measurements PD Measurements PD Measurements 5 days 1 Week 1 Week 5 days 5 days

  4. Model for Crossover Design

  5. procglmdata = allperiodanaly; class sequence subject period trt; model fenoav = sequence subject(sequence) period trt/solution; random subject(sequence); run;

  6. procmixeddata = allperiodanaly; class sequence subject period trt; model fenoav = sequence period trt; random subject(sequence); lsmeans trt/ pdiff cl; run;

  7. Baseline

  8. Baseline - Covariate • Average baseline values not significantly different • Presence of significant carryover effects (p-value < 0.05)

  9. Carryover Effect

  10. * Covariates tested for carryover; procmixeddata = allperiodanaly; class sequence subject period trt; modelfenoav = sequence period fenobtrt carry1 carry2; random subject(sequence); lsmeanstrt/ pdiffcle; run;

  11. Results • β cannot be forced to be 1

  12. Results

  13. Results • Reduced impact of the baseline values while using ANCOVA can explain the absence of carryover effects

  14. Conclusions • Day 5 data suitable for analysis • Maximum dose resolution • No carryover effect • Baseline adjustment • Simple difference increases the variability and introduces carryover effects • ANCOVA is the preferred method • Crossover design model with baseline values as covariates will be used for future simulations

More Related